first edition (1980) of the Orange Book - FDA Law Blog

More documents

Recommendations

Info

APPROVED PRESCRIPTION DRUG PRODUCTSDRUG PRODUCT LIST34CYCLOBENZAPRINE HYDROCHLORIDETABLET; ORALFLEXERILMERCK SHARP & DOHME5MG * 10MGCYCRIMINE HYDROCHLORIDETABLET; ORALPAGITANE HCLELI LILLY1. 25MG * 2. 5MGCYCLOPENTOLATE HYDROCHLORIDESOLUTION/DROPS; OPHTHALMICCYCLOGYLAT ALCON LABS l?0.5% * 27-CYCLOPEHTOLATE HCLAT BARNES-HIND PHARMS l?AT MAURRY BIOLOGICAL l?CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDESOLUTION/DROPS; OPHTHALMICCYCLOMYDRILALCON LABS 0.2%;1%CYPROHEPTADINE HYDROCHLORIDESYRUP; ORALCYPROHEPTADINE HCLAA NATL PHARM MFG/BARRE 2MG/5MLPERIACTIHAA MERCK SHARP & DOHME 2MG/5MLTABLET; ORALCYPROHEPTADIHE HCLAA BOLAR PHARMAA CHELSEA LABSAA MYLAN PHARMSAA ZENITH LABSPERIACTIHAA MERCK SHARP & DOHME4MG4MG4MG~4MGCYCLOPHOSPHAMIDEINJECTABLE; INJECTIONCYTOXAHMEAD JOHNSON/BMTABLET; ORALCYTOXAHMEAD JOHNSON/BMCYCLOSERINECAPSULE; ORALSEROMYCINELI LILLYCYCLOTHIAZIDETABLET; ORALANHYDROHELI LILLY100MG/VIAL * 200MGIVIAL * SOOMG/VIAL25MG * 50MG250NG2MGCYTARABINEINJECTABLE; INJECTIONCYTOSAR-UUPJOHNDACARBAZINE100MG/VIAL * SOOMG/VIALIHJECTABLE; INJECTIONDTIC-DOMEDONE LABS/MILES LABS IOOMG/VIAL * 200MG/VIALDACTINOMYCININJECTABLE; INJECTIONCOSMEGENMERCK SHARP & DOHME500 UGM/VIAL
APPROVED PRESCRI~TIOHDRUG PRODUCTSDRUG PRODUCT LISTssDANAZOLDEFEROXAMINE MESYLATECAPSULE; ORALDANOCRINEWINTHROP L/STERLING200MGINJECTABLE; INJECTIONDESFERAL MESYLATECIBA PHARMSOOMG/VIALDANTROLENE SODIUMDEMECARIUM BROMIDECAPSULE; ORALDANTRIUMNORWICH-EATON PHARMINJECTABLE; INJECTIONDANTRIUMNORWICH-EATON PHARMSUSPENSION; ORALDANTRIUMNORWICH-EATON PHARMDAPSONETABLET; ORALAVLOSULFONBP AYERST LABS/AtlHODAPSONEBP JACOBUS PHARMDAUNORUBICIN HYDROCHLORIDEINJECTABLE; INJECTIONCERUBIDINEIVES LABS/AMHO2SMG * SOMG * 7SMG * 100MG20MG/VIAL2SMG/SML25MG * 100MG2SMG * 100tlGEQ 20MG BASE/VIALSOLUTION/DROPS; OPHTHALMICHUtlORSOLMERCK SHARP & DOHME O.12SY. * O.2SY.DEMECLOCYCLINE HYDROCHLORIDECAPSULE; ORALDECLOMYCINLEDERLE LABS/AM CYAN lS0MGSYRUP; ORALDECLOMYCINLEDERLE LABS/AM CYAN 7SMG/SMLTABLET; ORALDECLOMYCINLEDERLE LABS/AM CYAN 75MG * lS0MG * 300MGDESERPIDINETABLET; ORALHARMONYLABBOTT LABSDESERPIDINE; HYDROCHLOROTHIAZIDE100 UGM * 2S0 UGMDECAMETHONIUM BROMIDEINJECTABLE; INJECTIONSYNCURINEBURROUGHS WELLCOME1MG/MLTABLET; ORALORETICYL FORTEABBOTT LABSORETICYL 25ABBOTT LABSORETICYL 50ABBOTT LABS2S0 UGM;25MG125 UGM;2SMG125 UGM;50MG
Page 5:
RXD AND DRUG ACMINISTRATIONAPProVED
Page 9:
approved application, a list of app
Page 12 and 13:
products that have been approved" i
Page 14 and 15:
To assist the user in relating the
Page 16 and 17: an evaluatien of therapeutic equiva
Page 18 and 19: ioavailability data is required for
Page 20 and 21: B - Drug products that FDA does not
Page 22 and 23: and the rate of absorption.pharmace
Page 24 and 25: 4. Erythromycin stearate Tablets -
Page 27 and 28: II. LISTINGSA. FORMAT GUIDEThis p..
Page 29 and 30: CURRENT STATUS - POSSIBLY EFFECTIVE
Page 31 and 32: DRUG ProDUCT EKAMPLESSingle Ingredi
Page 33 and 34: APPROVED PRESCRIPTION DRUG PRODUCTS
Page 55 and 56: j./APPROVED PRESCRIPTION DRUG PRODU
Page 65: -,----APPROVED PRESCRIPTION DRUG PR
Page 77 and 78: DIMENHYDlHNATEAPPROVED PRESCRIPTION
Page 81 and 82: ------"".,APPROVED PRESCRIPTION DRU
Page 91 and 92: APPROVED ¥RESCRIPTION DRUG PRODUCT
Page 95 and 96: '''"APPROVED PRESCRIPTION DRUG PROD
Page 97 and 98: ----..//APPROVED PRESCRIPTION DRUG
Page 117 and 118:
APPROVED PRESCRIPTION DRUG PRODUCTS
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
"~''''''-- .APPROVED PRESCRIPTION D
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
PERCORTEN PIVALATE, DESOXYCORTICOST
Page 191 and 192:
Page 193 and 194:
Page 195:
oAPPROVED PRESCRIPTION DRUG PRODUCT
Page 198 and 199:
Page 200 and 201:
Page 202 and 203:
Page 204 and 205:
Page 206 and 207:
Page 208 and 209:
Page 210 and 211:
Page 212 and 213:
Page 214 and 215:
Page 216 and 217:
Page 218 and 219:
Page 220 and 221:
Page 222 and 223:
Page 224 and 225:
APPROVED PRESCRIPTIOH DRUG PRODUCTS
Page 226 and 227:
Page 228 and 229:
Page 230 and 231:
Page 232 and 233:
Page 234 and 235:
Page 237 and 238:
Page 239 and 240:
Page 241 and 242:
Page 243:
Page 246 and 247:
PRESCRIPTION DRUG PRODUCTS DEEMED A
Page 248 and 249:
Page 250 and 251:
show all

first edition (1980) of the Orange Book - FDA Law Blog

Create successful ePaper yourself

Delete template?

Save as template?